ARCHIVES

Sandra Swain Is Acting Chief Of NCI’s Medicine Branch.

This article is from The Cancer Letter archive.

Vol. 26 No. 29 | July 21, 2000

Download PDF Visit The Full Archive

Related Articles

Program Announcement: Breast Cancer Research

May 28, 1993

In Brief: Oliverio Moves to DEA; Kushner Blass NIH Slow Pay; DeVita Welcomes Hawkin’s Probe

February 6, 1981

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

NCCTG Plans To Conduct Phase II Study Of Brostallicin Plus Cisplatin For mTNBC

April 30, 2010

Centers Agree To Broader Phase 1 Availability; Cool to Idea Of Distributing Group C Drugs

November 16, 1990

NCI Cooperative Group Clinical Trials Approved

May 29, 2009